Search

everythinglearnresearchcommunity

for

Search:↓

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

A(1-7) treatment reduces symptoms of lupus in mice.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Rhizobacterial strain RT3 helps lettuce survive drought by producing protective substances like proline.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.